XML 65 R53.htm IDEA: XBRL DOCUMENT v3.22.1
Stock–Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Exercise Prices of Common Stock Options

 

Stock   Number of Shares 
Price   that Vest 
$14.30    114,035 
$22.00    151,522 
$33.00    151,522 
$44.00    151,522 
      568,601 
Schedule of Unrecognized Compensation Expense

Unrecognized compensation expense related to the stock-based compensation awards and equity-based awards as of December 31, 2021 was as follows:

 

   As of December 31, 2021 
   Restricted Stock Awards   Common Stock Awards   Common Equity Awards   Outside Options   Publisher Partner Warrants   ABG Warrants   Totals 
Unrecognized compensation expense  $2,354,832   $      -   $  45,556,247   $37,694   $       -   $  2,433,889   $  50,382,662 
Weighted average period expected to be recognized (in years)   1.41    -    1.98    0.19    -    1.67    1.94 
ABG Warrants [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Exercise Prices of Common Stock Options

The exercise prices of the ABG Warrants outstanding and exercisable are as follows as of December 31, 2021.

 

Exercise   Outstanding   Exercisable 
Price   (Shares)   (Shares) 
$9.24    749,655    208,238 
$18.48    249,885    91,625 
      999,540    299,863 
Schedule of Warrants Activity

A summary of the ABG Warrant activity during the years ended December 31, 2021 and 2020 is as follows:

 

   Number of Shares   Weighted Average   Weighted Average Remaining Contractual Life 
   Unvested   Vested   Exercise Price   (in years) 
ABG Warrants outstanding at January 1, 2020   999,540    -   $13.86    9.46 
Vested   (99,954)   99,954    13.86      
ABG Warrants outstanding at December 31, 2020   899,586    99,954    13.86    8.46 
Vested   (199,909)   199,909    12.06      
ABG Warrants outstanding at December 31, 2021   699,677    299,863    11.55    7.46 
Summary of Stock-based Compensation

Stock–based compensation and equity-based expense charged to operations or capitalized during the years ended December 31, 2021 and 2020 are summarized as follows:

 

   Year Ended December 31, 2021 
   Restricted   Common   Common       Publisher         
   Stock   Stock   Equity   Outside   Partner   ABG     
   Awards   Awards   Awards   Options   Warrants   Warrants   Totals 
Cost of revenue  $196,651   $303,899   $6,974,374   $2,981   $    -   $-   $7,477,905 
Selling and marketing   -    34,832    5,265,382    75,653    -    -    5,375,867 
General and administrative   1,535,865    174,123    13,879,175    234,101    -    1,816,485    17,639,749 
Total costs charged to operations   1,732,516    512,854    26,118,931    312,735    -    1,816,485    30,493,521 
Capitalized platform development   11,128    7,101    2,018,993    8,042    -    -    2,045,264 
Total stock-based compensation  $  1,743,644    519,955   $  28,137,924   $  320,777   $        -   $  1,816,485   $  32,538,785 

 

   Year Ended December 31, 2020 
   Restricted   Common   Common       Publisher         
   Stock   Stock   Equity   Outside   Partner   ABG     
   Awards   Awards   Awards   Options   Warrants   Warrants   Totals 
Cost of revenue  $163,181   $156,043   $3,975,625   $8,394   $36,673   $-   $4,339,916 
Selling and marketing   1,486,722    114,640    2,454,432    272,431    -    -    4,328,225 
General and administrative   317,982    615,604    3,439,803    150,577    -    1,449,074    5,973,040 
Total costs charged to operations   1,967,885    886,287    9,869,860    431,402    36,673    1,449,074    14,641,181 
Capitalized platform development   361,519    178,284    1,062,792    6,400    -    -    1,608,995 
Total stock-based compensation  $2,329,404    1,064,571   $ 10,932,652   $ 437,802   $36,673   $ 1,449,074   $  16,250,176 
Equity 2019 Incentive Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Exercise Prices of Common Stock Options

The exercise prices under the 2019 Plan for the common equity awards outstanding and exercisable are as follows as of December 31, 2021:

 

Exercise   Outstanding   Exercisable 
Price   (Shares)   (Shares) 
 No exercise price    1,802,686    166,574 
 $7.00 to $9.99    132,281    83,496 
 $10.00 to $12.99    1,802,249    974,941 
 $13.00 to $15.99    334,825    135,689 
 $16.00 to $18.99    1,803,385    664,881 
 $19.00 to $21.99    1,032,028    26,951 
      6,907,454    2,052,532 
Stock Options Outside 2016 Plan and 2019 Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Option Activity

A summary of outside option activity during the years ended December 31, 2021 and 2020 is as follows:

 

           Weighted 
           Average 
       Weighted   Remaining 
   Number   Average   Contractual 
   of   Exercise   Life 
   Shares   Price   (in Years) 
Outside options outstanding at January 1, 2020   169,304   $4.62    9.04 
Forfeited   (8,879)   10.12      
Expired   (21,697)   8.58      
Outside options outstanding at December 31, 2020   138,728    10.12    8.07 
Forfeited   (31)   7.70      
Expired   (60)   7.70      
Outside options outstanding at December 31, 2021   138,637    10.08    7.07 
Outside options exercisable at December 31, 2021   132,955    9.98    7.07 
Outside options not vested at December 31, 2021   5,682           
Schedule of Exercise Prices of Common Stock Options

The exercise prices of outside options outstanding and exercisable are as follows as of December 31, 2021:

 

Exercise   Outstanding   Exercisable 
Price   (Shares)   (Shares) 
 $7.00 to $9.99    70,455    70,455 
 $10.00 to $12.99    68,182    62,500 
      138,637    132,955 
Publisher Partner Warrant [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Exercise Prices of Common Stock Options

The exercise prices of the Publisher Partner Warrants outstanding and exercisable are as follows as of December 31, 2021.

 

Exercise   Outstanding   Exercisable 
Price   (Shares)   (Shares) 
 $20.00 to $24.99    6,390    1,844 
 $25.00 to $29.99    17,009    12,918 
 $30.00 to $34.99    2,521    2,521 
 $35.00 to $39.99    4,888    1,138 
 $40.00 to $44.99    4,749    2,295 
 $45.00 to $49.99    50    50 
      35,607    20,766 
Schedule of Warrants Activity

A summary of the Publisher Partner Warrants activity during the years ended December 31, 2021 and 2020 is as follows:

 

           Weighted 
           Average 
       Weighted   Remaining 
   Number   Average   Contractual 
   of   Exercise   Life 
   Shares   Price   (in Years) 
Publisher Partner Warrants outstanding at January 1, 2020   42,707   $32.12    2.57 
Forfeited   (6,819)          
Publisher Partner Warrants outstanding at December 31, 2020   35,888    29.48    1.50 
Expired   (281)          
Publisher Partner Warrants outstanding at December 31, 2021   35,607    28.33    0.50 
Publisher Partner Warrants exercisable at December 31, 2021   20,766    28.88    0.53 
Publisher Partner Warrants not vested at December 31, 2021   14,841           
Publisher Partner Warrants available for future grants at December 31, 2021   55,303           
Common Stock Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Fair Value of Stock Options Assumptions

The fair value of common stock awards granted during the year ended December 31, 2020 were calculated using the Black-Scholes option pricing model under the Probability Weighted Scenarios utilizing the following assumptions:

 

   Up-list   No Up-list 
Risk-free interest rate   0.45%   0.45%
Expected dividend yield   0.00%   0.00%
Expected volatility   71.00%   132.00%
Expected life   6.0 years    6.0 years 
Summary of Stock Option Activity

A summary of the common stock award activity during the years ended December 31, 2021 and 2020 is as follows:

 

           Weighted 
           Average 
       Weighted   Remaining 
   Number   Average   Contractual 
   of   Exercise   Life 
   Shares   Price   (in Years) 
Common stock awards outstanding at January 1, 2020   366,571   $13.64    8.34 
Granted   10,637    19.80      
Exercised   (316)   12.32      
Forfeited   (27,327)   23.98      
Expired   (35,823)   11.66      
Common stock awards outstanding at December 31, 2020   313,742    18.92    7.50 
Granted   8,041    27.42      
Forfeited   (176)   12.32      
Expired   (28,266)   26.84      
Common stock awards outstanding at December 31, 2021   293,341    18.49    6.49 
Common stock awards exercisable at December 31, 2021   293,341    18.49    6.49 
Common stock awards not vested at December 31, 2021   -           
Common stock awards available for future grants at December 31, 2021   161,204           
Schedule of Exercise Prices of Common Stock Options

The exercise prices under the 2016 Plan for the common stock awards outstanding and exercisable are as follows as of December 31, 2021:

 

Exercise   Outstanding   Exercisable 
Price   (Shares)   (Shares) 
 Under $11.00    32,591    32,591 
 $11.01 to $16.50    171,797    171,797 
 $16.51 to $22.00    -    - 
 $22.01 to $27.50    41,486    41,486 
 $27.51 to $33.00    910    910 
 $33.01 to $38.50    11,366    11,366 
 $38.51 to $44.00    34,509    34,509 
 $44.01 to $49.50    682    682 
      293,341    293,341 
Common Equity Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Fair Value of Stock Options Assumptions

The fair value of common equity awards granted during the years ended December 31, 2021 and 2020 were calculated using the Black-Scholes option pricing model for the time-based and performance-based awards by an independent appraisal firm under the Probability Weighted Scenarios utilizing the following assumptions:

 

  

Year Ended

December 31, 2021		  

Year Ended

December 31, 2020		 
   Up-list   No Up-list   Up-list   No Up-list 
Risk-free interest rate   0.16% - 1.48%    0.16% - 1.48%    0.20% - 0.79%    0.20% - 0.79% 
Expected dividend yield   0.00%   0.00%   0.00%   0.00%
Expected volatility   65.00% - 90.00%    133.00% - 140.00%    61.00% - 91.00%    61.00% - 142.00% 
Expected life   3.0 – 6.0 years    3.0 – 6.0 years    3.0 – 6.7 years    3.0 – 6.7 years 
Summary of Stock Option Activity

A summary of the common equity award activity during the years ended December 31, 2021 and 2020 is as follows:

 

           Weighted 
           Average 
       Weighted   Remaining 
   Number   Average   Contractual 
   of   Exercise   Life 
   Shares   Price   (in Years) 
Common equity awards outstanding at January 1, 2020   2,955,166   $11.66    9.43 
Granted   1,154,263    15.62      
Forfeited   (379,199)   13.42      
Expired   (124)   12.32      
Common equity awards outstanding at December 31, 2020   3,730,106    12.76    8.65 
Granted   3,981,907    10.86      
Exercised   (7,893)   10.12      
Issued   (22,728)   -      
Forfeited   (433,982)   16.01      
Expired   (339,956)   12.02      
Common equity awards outstanding at December 31, 2021 (1)   6,907,454    11.23    8.63 
Common equity awards exercisable at December 31, 2021   2,052,532    12.04    8.16 
Common equity awards not vested at December 31, 2021 (1)   4,854,922           
Common equity awards available for future grants at December 31, 2021 (2)   1,408,443           

(1)Includes 1,814,044 restricted stock units outstanding

(2)Excludes 70,465 restricted stock awards vested as of December 31, 2021 that were issued under the 2019 Plan
Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Restricted Stock Units Activity

A summary of the restricted stock unit activity during the years ended December 31, 2021 and 2020 is as follows:

 

      

Weighted Average

 
   Number of Shares   Grant-Date 
   Unvested   Vested   Fair Value 
Restricted stock units outstanding at January 1, 2020   109,091       -   $9.90 
Forfeited   (109,091)   -      
Restricted stock units outstanding at December 31, 2020   -    -    - 
Forfeited   -   -      
Restricted stock units outstanding at December 31, 2021   -    -    -